MYLAN MS ADVOCATE Trademark

Trademark Overview

On Wednesday, May 6, 2015, a trademark application was filed for MYLAN MS ADVOCATE with the United States Patent and Trademark Office. The USPTO has given the MYLAN MS ADVOCATE trademark a serial number of 86621006. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 7, 2024. This trademark is owned by Mylan Pharmaceuticals, Inc.. The MYLAN MS ADVOCATE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information to patients relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals for the treatment of multiple sclerosis
mylan ms advocate

General Information

Serial Number86621006
Word MarkMYLAN MS ADVOCATE
Filing DateWednesday, May 6, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 7, 2024
Registration Number5346678
Registration DateTuesday, November 28, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Goods and ServicesProviding information to patients relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals for the treatment of multiple sclerosis

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 7, 2024
Primary Code044
First Use Anywhere DateThursday, October 5, 2017
First Use In Commerce DateThursday, October 5, 2017

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Friday, July 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 9, 2015NEW APPLICATION ENTERED
Friday, May 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 21, 2015ASSIGNED TO EXAMINER
Thursday, June 25, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 10, 2015ASSIGNED TO LIE
Thursday, October 20, 2016SOU EXTENSION 2 FILED
Wednesday, August 5, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 25, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 16, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2016SOU EXTENSION 1 FILED
Wednesday, April 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 25, 2016SOU EXTENSION 1 GRANTED
Tuesday, April 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2017SOU EXTENSION 3 FILED
Wednesday, March 22, 2017SOU EXTENSION 3 GRANTED
Friday, March 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2016TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 25, 2016PETITION TO REVIVE-GRANTED
Tuesday, October 25, 2016SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, October 26, 2016NOTICE OF REVIVAL - E-MAILED
Wednesday, November 2, 2016SOU EXTENSION 2 GRANTED
Thursday, November 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 25, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 26, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 28, 2017REGISTERED-PRINCIPAL REGISTER
Friday, September 29, 2017SOU TEAS EXTENSION RECEIVED
Friday, September 29, 2017SOU EXTENSION 4 FILED
Friday, September 29, 2017SOU EXTENSION 4 GRANTED
Tuesday, October 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, October 5, 2017USE AMENDMENT FILED
Monday, November 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 7, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

advocate mylan pharmaceuticals properties treatment multiple sclerosis therapeutic prophylactic information patients relating